Established in 2016, Saptagir Laboratories Private is a company dedicated to manufacturing and supplying Active Pharmaceutical Ingredients (APIs) and Intermediates across various therapeutic categories, with a specific focus on Anti-Fungal and Anti-Platelet products. The company aims to achieve market leadership in developing innovator molecules for both domestic and international markets. Saptagir Laboratories Private is recognized as one of the primary manufacturers in Asia for Terbinafine Hydrochloride, Prasugrel, Ezetimibe, Solifenacine Succinate, and Pregabalin. Additionally, the company offers DMF and EU Written Confirmation for its premier product, Terbinafine Hydrochloride, while also currently filing for CEP & Korean DMF.